Prevention of Reocclusion After Prosthetic Bypass Operations in the Femoro-Popliteal Region: A Comparative Study of Pentoxifylline Versus Acetylsalicylic Acid

Abstract

One hundred eighteen patients (88 males, 30 females, mean age 67.2 years, age range 42 to 87 years) with successfully performed synthetic prosthetic by pass operations in the femoro-popliteal area were submitted in an open random ized study of two groups of 59 subjects to oral treatment by 400 mg pentoxifylline in special patented slow-release formulation or 500 mg ASA tid from two days before operation until twelve months after operation (with par enteral administration of both drugs on the day of surgery and two days after surgery). Effectiveness of prevention of reocclusion was assessed by patency rates and drug tolerability.

The examinations (clinical status, pulse palpation, Doppler-pressure mea surement, arteriography) were carried out before and on days five or six after operation, and also after three, six, nine, and twelve months of the follow-up period.

The life table analysis disclosed no significantly different patency rates (75% for the pentoxifylline-treated group and 74% for the ASA cohort).

A significantly superior tolerability was found in the patients treated with pentoxifylline, 6 patients (10%) reporting adverse reactions as compared with 33 (56%) in the ASA-treated group. The side effects consisted mostly of gastric upset, dizziness, and gastric hemorrhage. The medication was discontinued in 6 patients on pentoxifylline and 12 on ASA.

Get full access to this article

View all access options for this article.

References

Ambrus JL , Ambrus CM , Taheri SA , et al: Red cell flexibility and platelet aggregation in patients with chronic obstructive vascular disease (COAD) and study of therapeutic approaches . Angiology 35:418, 1984.

Angelkort B. , Kiesewetter H. : Influence of risk factors and coagulation phenomena on the fluidity of blood in chronic arterial occlusive disease. Scand J Clin Lab 41 (Suppl. 156):185, 1981.

Bollinger A. , Fritschy J. , Torres C. , Piquerez MJ : Thrombozytenaggregationshemmer nach offener oder halboffener Endarterektomie—vorläufige Resultate einer prospektiven Studie. Vasa 7:82, 1978.

De Gaetano G. , Cerletti C. , Bertele V. : Pharmacology of antiplatelet drugs and clinical trials on thrombosis prevention: A difficult link. Lancet Oct. 30, 1982, p. 974.

Dixon WJ , et al: BMDP Statistical Software 1983. Berkeley : University of California Press, 1983.

Gall FP , Franke F. , Raithel D. : Indications, technique and results in 336 tibioperoneal reconstructions . Cardiovasc Dis 7:266, 1980.

Hess H. , Mietaschk A. , Deichsel G. : Drug-induced inhibition of platelet function delays progression of peripheral occlusive arterial disease. Lancet Feb 23, 1985, p. 415.

Kaplan EL , Meier P. : Nonparametric estimation from incomplete observations. J Am Statist Assoc 53:437, 1958.

Lucas MA : Prevention of postoperative thrombosis in peripheral arteriopathies. Pentoxifylline vs conventional antiaggregants: A six month randomized follow-up study. Angiology 35:443, 1984.

10.

Mantel N. : Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163, 1966.

11.

Müller R. : Pentoxifylline—a biomedical profile. J Med 10:307, 1979.

12.

Müller R. , Lehrach F. : Haemorheological role of platelet aggregation and hypercoagulability in microcirculation: Therapeutical approach with pentoxifylline. Pharmatherapeutica 2:372, 1980.

13.

Oblath RW , Buckley FO , Green RM , et al: Prevention of platelet aggregation and adherence to prosthetic vascular grafts by aspirin and dipyridamole. Surgery 84:37, 1978.

14.

Poggesi L. , Scarti L. , Boddi M. , et al: Pentoxifylline treatment in patients with occlusive peripheral arterial disease. Circulatory changes and effects on prostaglandin synthesis . Angiology 36:618, 1985.

15.

Raithel D. : Longterm results of femoropopliteal/tibial bypasses with special references to reoperation in former femoropopliteal procedures. J Cardiovasc Surg 21:541, 1980.

16.

Seiffge D. : The antithrombotic effect of pentoxifylline in the laser induced thrombus model in rat mesenteric arterioles. In: Proc 3rd German-Japanese Congr of Angiology, Heidelberg, 1984, ed. by Mauser HJ. Demeter, Gräfelfing, 1985, p. 86.

17.

Schoop W. : Progression der arteriellen Verschluβkrankheiten unter Aggregationshemmem . In: Gefäβwand, Rezidivprophylaxe—Raynaud Syndrom , ed. by Ehringer H , Betz E , Bollinger A. Baden-Baden, G. Witzstrock, 1979, p. 262.

18.

Schricker KTh , Raithel D. , Juchelka L. : Einflu βvon Aspirin auf die Plättchenfunktion bei gefäβchirurgischen Eingriffen. Münch med Wochenschr 119:961, 1977.

19.

Weichert W. , Breddin HK : Antithrombotic effects of acetylsalicylic acid (ASA) and pentoxifylline in laser-induced thrombosis in rat mesenteric vessels. Vasa 14:280, 1985.

20.

Weithmann KU : Reduced platelet aggregation by Pentoxifylline stimulated prostacycline release. Vasa 10:249, 1981.

21.

Wewalka F. , Ahmadi A. , Pesendorfer FX , Pötzi R. : Gastrointestinale Komplikationene bei Langzeittherapie mit Acetylsalicylsäure . In: Gefäβwand, Rezidivprophylaxe, Raynaud-Syndrom, ed. by Ehringer H , Betz E , Bollinger A , Deutsch E. Baden-Baden, G. Witzstrock , 1979, p. 279.